ATE286387T1 - Clarithromycin enthaltende zubereitung mit verlängerter freisetzung - Google Patents

Clarithromycin enthaltende zubereitung mit verlängerter freisetzung

Info

Publication number: ATE286387T1
Authority: AT; Austria
Prior art keywords: clarithromycin; sustained release; extended release; preparation containing; release preparation
Prior art date: 2000-09-22

Application number

AT01971528T

Other languages

English (en)

Inventor

Francis Vanderbist

Antonio Sereno

Philippe Baudier

Original Assignee

Galephar M F

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-22

Filing date

2001-09-21

Publication date

2005-01-15

2001-09-21 Application filed by Galephar M F filed Critical Galephar M F

2005-01-15 Application granted granted Critical

2005-01-15 Publication of ATE286387T1 publication Critical patent/ATE286387T1/de

Links

AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 title abstract 4
229960002626 clarithromycin Drugs 0.000 title abstract 4
238000013265 extended release Methods 0.000 title 1
238000013268 sustained release Methods 0.000 abstract 4
239000012730 sustained-release form Substances 0.000 abstract 4
239000011248 coating agent Substances 0.000 abstract 2
238000000576 coating method Methods 0.000 abstract 2
239000008188 pellet Substances 0.000 abstract 2
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
229920003176 water-insoluble polymer Polymers 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)

AT01971528T 2000-09-22 2001-09-21 Clarithromycin enthaltende zubereitung mit verlängerter freisetzung ATE286387T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
BE0000112		2000-09-22
PCT/BE2001/000164 WO2002024174A2 (en)	2000-09-22	2001-09-21	Sustained release composition containing clarithromycin

Publications (1)

Publication Number	Publication Date
ATE286387T1 true ATE286387T1 (de)	2005-01-15

Family

ID=3862551

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01971528T ATE286387T1 (de)	2000-09-22	2001-09-21	Clarithromycin enthaltende zubereitung mit verlängerter freisetzung

Country Status (9)

Country	Link
US (1)	US20040048814A1 (de)
EP (1)	EP1318792B1 (de)
AT (1)	ATE286387T1 (de)
AU (1)	AU2001291526A1 (de)
CA (1)	CA2423172A1 (de)
DE (1)	DE60108255T2 (de)
ES (1)	ES2234885T3 (de)
PT (1)	PT1318792E (de)
WO (1)	WO2002024174A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6544555B2 (en)	2000-02-24	2003-04-08	Advancis Pharmaceutical Corp.	Antibiotic product, use and formulation thereof
US6565882B2 (en) *	2000-02-24	2003-05-20	Advancis Pharmaceutical Corp	Antibiotic composition with inhibitor
US6541014B2 (en) *	2000-10-13	2003-04-01	Advancis Pharmaceutical Corp.	Antiviral product, use and formulation thereof
US20020068078A1 (en) *	2000-10-13	2002-06-06	Rudnic Edward M.	Antifungal product, use and formulation thereof
US7037523B2 (en)	2001-11-02	2006-05-02	Wockhardt Limited	Controlled release compositions for macrolide antimicrobial agents
US7137696B2 (en) *	2003-01-09	2006-11-21	Con-Trol-Cure, Inc.	Ink jet UV curing
WO2005004919A2 (en) *	2003-07-02	2005-01-20	Eurand, Inc.	Extended release systems for macrolide antibiotics
CA2533292C (en) *	2003-07-21	2013-12-31	Advancis Pharmaceutical Corporation	Antibiotic product, use and formulation thereof
EP1648418A4 (de) *	2003-07-21	2011-11-16	Middlebrook Pharmaceuticals Inc	Antibiotisches produkt, seine verwendung und formulierung
EP1648415A4 (de) *	2003-07-21	2011-11-16	Middlebrook Pharmaceuticals Inc	Antibiotisches produkt, seine verwendung und formulierung
WO2005016311A1 (en) *	2003-08-11	2005-02-24	Advancis Pharmaceutical Corporation	Robust pellet
CA2535398C (en) *	2003-08-12	2013-11-12	Advancis Pharmaceuticals Corporation	Antibiotic product, use and formulation thereof
EP1658034A4 (de) *	2003-08-29	2011-06-22	Middlebrook Pharmaceuticals Inc	Antibiotisches produkt, seine verwendung und formulierung
WO2005027877A1 (en) *	2003-09-15	2005-03-31	Advancis Pharmaceutical Corporation	Antibiotic product, use and formulation thereof
CA2549225A1 (en)	2003-12-04	2005-06-16	Pfizer Products Inc.	Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
US6984403B2 (en)	2003-12-04	2006-01-10	Pfizer Inc.	Azithromycin dosage forms with reduced side effects
AU2004308419B2 (en) *	2003-12-24	2011-06-02	Victory Pharma, Inc.	Enhanced absorption of modified release dosage forms
KR101122096B1 (ko) *	2004-05-20	2012-03-15	주식회사종근당	쓴맛을 차폐하면서 우수한 용출률을 보이는클라리스로마이신의 약제학적 조성물 및 그의 제조 방법
US8715727B2 (en) *	2004-07-02	2014-05-06	Shionogi Inc.	Tablet for pulsed delivery
CN1322866C (zh) *	2004-10-12	2007-06-27	广州贝氏药业有限公司	一种多单元缓释制剂
FR2879075B1 (fr) *	2004-12-15	2007-01-19	Adisseo France Sas Soc Par Act	Procede de preparation de granules de principe actif hydrophile par extrusion
US8481565B2 (en)	2004-12-27	2013-07-09	Eisai R&D Management Co., Ltd.	Method for stabilizing anti-dementia drug
KR100676075B1 (ko)	2005-02-17	2007-02-01	한국유나이티드제약 주식회사	경구투여용 클래리스로마이신 함유 펠렛 제제
US8778924B2 (en)	2006-12-04	2014-07-15	Shionogi Inc.	Modified release amoxicillin products
US8357394B2 (en)	2005-12-08	2013-01-22	Shionogi Inc.	Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en)	2006-05-05	2012-10-30	Shionogi Inc.	Pharmaceutical compositions and methods for improved bacterial eradication

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US293885A (en) *		1884-02-19		Milton jackson
US4173626A (en) *	1978-12-11	1979-11-06	Merck & Co., Inc.	Sustained release indomethacin
US4808411A (en) *	1987-06-05	1989-02-28	Abbott Laboratories	Antibiotic-polymer compositions
CA2182282C (en) *	1994-02-16	2006-04-18	Jacqueline E. Briskin	Process for preparing fine particle pharmaceutical formulations
AUPO637197A0 (en) *	1997-04-23	1997-05-15	F.H. Faulding & Co. Limited	Taste-masked pharmaceutical compositions
WO2001035930A1 (en) *	1999-11-16	2001-05-25	Ranbaxy Laboratories Limited	Taste masked oral compositions
AU3984101A (en) *	2000-02-24	2001-09-03	Advanced Pharma Inc	Antibiotic and antifungal compositions

2001
- 2001-09-21 ES ES01971528T patent/ES2234885T3/es not_active Expired - Lifetime
- 2001-09-21 CA CA002423172A patent/CA2423172A1/en not_active Abandoned
- 2001-09-21 AT AT01971528T patent/ATE286387T1/de not_active IP Right Cessation
- 2001-09-21 DE DE60108255T patent/DE60108255T2/de not_active Expired - Lifetime
- 2001-09-21 EP EP01971528A patent/EP1318792B1/de not_active Expired - Lifetime
- 2001-09-21 AU AU2001291526A patent/AU2001291526A1/en not_active Abandoned
- 2001-09-21 US US10/380,620 patent/US20040048814A1/en not_active Abandoned
- 2001-09-21 PT PT01971528T patent/PT1318792E/pt unknown
- 2001-09-21 WO PCT/BE2001/000164 patent/WO2002024174A2/en not_active Ceased

Also Published As

Publication number	Publication date
PT1318792E (pt)	2005-04-29
ES2234885T3 (es)	2005-07-01
EP1318792B1 (de)	2005-01-05
AU2001291526A1 (en)	2002-04-02
WO2002024174A3 (en)	2002-09-26
EP1318792A2 (de)	2003-06-18
US20040048814A1 (en)	2004-03-11
DE60108255D1 (de)	2005-02-10
CA2423172A1 (en)	2002-03-28
DE60108255T2 (de)	2005-12-22
WO2002024174A2 (en)	2002-03-28

Legal Events

Date	Code	Title	Description
2005-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE60108255D1 (de)	2005-02-10	Clarithromycin enthaltende zubereitung mit verlängerter freisetzung
AP2001002237A0 (en)	2001-09-30	Hydrogel-driven drug dosage form.
GEP20043334B (en)	2004-03-10	Hydrogel-Driven Drug Dosage Form
DE60226012D1 (de)	2008-05-21	Geschmacksmaskierte pharmazeutische formulierungen
SE9704869D0 (sv)	1997-12-22	New pharmaceutical formulaton II
IS4146A (is)	1994-10-31	Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
GEP20032912B (en)	2003-03-25	Enteric Coated Pharmaceutical Tablets and Method of Manufacturing
GEP20053602B (en)	2005-08-10	Aripiprazole for Oral Administration
NO20016346L (no)	2002-02-18	Ny formulering
ATE355829T1 (de)	2007-03-15	Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung
GEP20053501B (en)	2005-05-10	Core Tablet for Controlled Release of Gliclazide after Oral Administration
DE60038536D1 (de)	2008-05-21	Matrixsystem mit verzögerter freisetzung für hochlösliche wirkstoffe
CY1105120T1 (el)	2010-03-03	Η αντιμετωπιση αναπνευστικων νοσων
DK1117383T3 (da)	2006-04-03	Doseringsformer omfattende terapeutisk formulering
EA200900270A1 (ru)	2009-08-28	Системы регулируемого высвобождения и способ их приготовления
YU31599A (sh)	2000-03-21	Brzo oslobadjajući i za ukus maskirajući farmaceutski oblik doze
ATE198152T1 (de)	2001-01-15	Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
ATE326264T1 (de)	2006-06-15	Pharmazeutische formulierungen mit kontrollierter wirkstoff-freigabe enthaltend milchsäure-polymer, sowie deren herstellung
MY130332A (en)	2007-06-29	Pharmaceutical formulation comprising iota-carrageenan and at least one neutral gelling polymer
NO20101070L (no)	2001-02-05	Fremgangsmate til dosering av et medikament, samt doseringsform
CA2383212A1 (en)	2001-03-08	Controlled release oral dosage suitable for oral administration
EA200300110A1 (ru)	2003-06-26	Композиция элетриптана в виде частиц
DE60028730D1 (de)	2006-07-27	Multipartikuläre bisoprolol formulierung
DE69627365D1 (de)	2003-05-15	Verabreichungssystem mit verzoegerter freisetzung sowie langwirkende narkotische analgetika und antagonisten
SE0001916D0 (sv)	2000-05-23	Novel formulation